TY - JOUR
T1 - Inflammatory fibroid polyp of the gallbladder bearing a platelet-derived growth factor receptor alpha mutation
AU - Martini, Maurizio
AU - Santoro, Luisa
AU - Familiari, Pietro
AU - Costamagna, Guido
AU - Ricci, Riccardo
PY - 2013
Y1 - 2013
N2 - The inflammatory fibroid polyp (IFP) is a benign lesion occurring in the digestive tract, mostly in the stomach and small bowel, composed of fibrovascular tissue infiltrated by inflammatory cells including eosinophils and mastocytes. Its pathogenesis has been controversial (reactive versus neoplastic). The recent finding of mutations in platelet-derived growth factor receptor α (PDGFRA) in most gastric and small intestinal IFPs supported their neoplastic etiology, moreover helping in their differential diagnosis. In the only gallbladder IFP reported so far, the diagnosis was based on morphologic and immunohistochemical grounds, which in current standards would probably be considered not fully conclusive. Conversely, the gallbladder IFP we report shows typical pathologic features supported by a PDGFRA mutation, similar to its usual gastric and small intestinal counterparts, constituting the first report of an unequivocal IFP at gallbladder level. Thus, IFPs must be considered in the differential diagnosis of gallbladder mesenchymal masses, and genetic analysis of PDGFRA is a helpful tool for this purpose.
AB - The inflammatory fibroid polyp (IFP) is a benign lesion occurring in the digestive tract, mostly in the stomach and small bowel, composed of fibrovascular tissue infiltrated by inflammatory cells including eosinophils and mastocytes. Its pathogenesis has been controversial (reactive versus neoplastic). The recent finding of mutations in platelet-derived growth factor receptor α (PDGFRA) in most gastric and small intestinal IFPs supported their neoplastic etiology, moreover helping in their differential diagnosis. In the only gallbladder IFP reported so far, the diagnosis was based on morphologic and immunohistochemical grounds, which in current standards would probably be considered not fully conclusive. Conversely, the gallbladder IFP we report shows typical pathologic features supported by a PDGFRA mutation, similar to its usual gastric and small intestinal counterparts, constituting the first report of an unequivocal IFP at gallbladder level. Thus, IFPs must be considered in the differential diagnosis of gallbladder mesenchymal masses, and genetic analysis of PDGFRA is a helpful tool for this purpose.
KW - Gallbladder Diseases
KW - Polyps
KW - Receptor, Platelet-Derived Growth Factor alpha
KW - Gallbladder Diseases
KW - Polyps
KW - Receptor, Platelet-Derived Growth Factor alpha
UR - http://hdl.handle.net/10807/52215
U2 - 10.5858/arpa.2012-0218-CR
DO - 10.5858/arpa.2012-0218-CR
M3 - Article
SN - 1543-2165
VL - 137
SP - 721
EP - 724
JO - ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
JF - ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
ER -